Sridhar Vasireddy, MD
Anesthesiology · San Antonio, TXNPI 1144214966
Payments from drug & device makers
Across 594 payments — averaging $30.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Abbott$4K
- Nevro Corp.$2K
- Boston Scientific$761
- Si-bone, Inc.$642
- Globus Medical$564
- plus $3K from 25 others
What the payments were for
- Travel & lodging$1,2717%
- Food & beverage$16,75593%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 152 | $7,123 |
| Abbott | 151 | $4,256 |
| Nevro Corp. | 78 | $1,736 |
| Boston Scientific | 20 | $761 |
| Si-bone, Inc. | 13 | $642 |
| Globus Medical | 11 | $564 |
| Relievant Medsystems, Inc. | 5 | $471 |
| Pfizer | 33 | $427 |
| Teva Pharmaceuticals USA, Inc. | 12 | $345 |
| Amgen(2 entities) | 6 | $301 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $248 |
| SPR Therapeutics, Inc | 3 | $211 |
| Assertio Therapeutics, Inc. | 53 | $168 |
| Collegium Pharmaceutical, Inc. | 8 | $133 |
| AbbVie(2 entities) | 6 | $112 |
| Vertex | 3 | $90 |
| Novartis | 4 | $65 |
| Scilex Pharmaceuticals Inc. | 4 | $63 |
| GRT US Holding, Inc. | 3 | $60 |
| MML US, Inc. | 2 | $53 |
| Biodelivery Sciences International, Inc. | 3 | $38 |
| Nalu Medical, Inc. | 1 | $26 |
| Stryker | 1 | $25 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
| Orthogenrx Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| IBSA Pharma Inc. | 1 | $12 |
| Fidia Pharma USA Inc. | 2 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$2,047
- Intracept$1,383
- KYPHON EXPRESS II KYPHOPAK TRAY$1,045
- PROCLAIM$725
- Senza Spinal Cord Stimulation System$560
- Neuromodulation Dspsbls and Accs$517
- Senza$423
- INTELLIS$275
- KRYSTEXXA$244
- iFuse Implant$230
- GENERAL PAIN MANAGEMENT$227
- Proclaim Plus SCS with FlexBurst360$169
- Proclaim IPG$165
- VANTA ADAPTIVESTIM$158
- Intracept RF Probe$150
- Omnia$150
- Embolization Spheres$125
- OCTRODE$120
- SPRINT PNS System$119
- AJOVY$119
How this compares
$18,026 in reported general payments places this provider in the 95th percentile of 3,899 anesthesiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,679 | $51,315 |
| BelbucaBuprenorphine Hcl | 25 | $18,068 |
| Buprenorphine | 47 | $15,582 |
| Xtampza ErOxycodone Myristate | 19 | $13,622 |
| Pregabalin | 497 | $11,824 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,883 |
| Hydrocodone-IbuprofenHydrocodone/Ibuprofen | 26 | $7,633 |
| Morphine Sulfate ErMorphine Sulfate | 143 | $7,412 |
| OxycontinOxycodone Hcl | 13 | $6,224 |
| Gabapentin | 514 | $5,793 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 202 | $5,618 |
| Baclofen | 283 | $4,481 |
| Hydromorphone Hcl | 254 | $4,382 |
| Tramadol Hcl | 427 | $4,023 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 204 | $3,926 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $133 | $31,69044 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,899 anesthesiology providers in Texas.
Other anesthesiology in San Antonio
- Maxim EckmannSan Antonio$612K
- Michael LittleSan Antonio$197K
- Maged MinaSan Antonio$66K
- Daneshvar SolankiLeague City$38M
- David BrownHouston$2.5M
- Holger EltzschigHouston$1.6M
- Julie GreeneFort Worth$1.1M
- Maria MatuszczakHouston$907K
- Ryan CaseyAustin$844K
- Richard TeamesFort Worth$746K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.